User:TrialsTabitha
Editor (rollback)·21,455 edits·since 2024/07
TrialsTabitha is an editor on PeptidePedia Wiki, editing since 2024 / 7.
Reads the supplementary appendices so you do not have to.
Editing record
21,455Total edits
21Logged here
16Articles touched
2024/07Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is clinical trials and evidence appraisal.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Shanghai ERP Biotechnology | 2 | 74 | 3% |
| Syringe dead space | 2 | 70 | 3% |
| Glucagon-like peptide-1 | 2 | 90 | 2% |
| Lyophilisation | 1 | 86 | 1% |
| Sharps disposal | 1 | 61 | 2% |
| Reconstitution calculator | 1 | 70 | 1% |
| Bachem Holding (Suzhou) | 1 | 86 | 1% |
| Trial data comparison | 1 | 78 | 1% |
| Peptide stability table | 1 | 74 | 1% |
| Shanghai Wibson Biotechnology | 1 | 78 | 1% |
| Incretin effect | 1 | 78 | 1% |
| ChinaPeptides | 1 | 86 | 1% |
| Beyond-use date | 1 | 82 | 1% |
| Qingdao Sigma Chemical | 1 | 66 | 2% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.